human immunodeficiency (O-antigen) antibody and antigen (Recombinant protein)

Diagnostic immunodeficiency virus-O antigen (HIV-O) antibodies (anti-human immunodeficiency, anti-O-antigen) and antigens (recombinant immunodeficiency virus-O antigen (HIV-O) protein) for Infectious disease O-antigen detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-IVD-P006-Tg001-Ag01 Recombinant human immunodeficiency virus-O antigen (HIV-O) O-antigen Protein 3090
GMP-IVD-P006-Tg001-Ab01 Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) 1953
GMP-IVD-P006-Tg001-Ab02 Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) 1953
GMP-IVD-P006-Tg001-Ab03 Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb) 1953
GMP-IVD-P006-Tg001-Ab04 Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-IVD-P006-Tg001-Ag01
Product Name Recombinant human immunodeficiency virus-O antigen (HIV-O) O-antigen Protein
Pathogen immunodeficiency virus-O antigen
Target/Biomarker human immunodeficiency(O-antigen)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation human immunodeficiency (O-antigen) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation.
Tag His
Products description Recombinant human immunodeficiency virus-O antigen (HIV-O) O-antigen Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-IVD-P006-Tg001-Ab01, GMP-IVD-P006-Tg001-Ab02
Product Name Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb)
Pathogen immunodeficiency virus-O antigen
Target/Biomarker human immunodeficiency(O-antigen)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human human immunodeficiency (O-antigen) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other human immunodeficiency (O-antigen) antibodies in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation.
Tag mFc
Products description Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-IVD-P006-Tg001-Ab03, GMP-IVD-P006-Tg001-Ab04
Product Name Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb)
Pathogen immunodeficiency virus-O antigen
Target/Biomarker human immunodeficiency(O-antigen)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Human human immunodeficiency (O-antigen) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other human immunodeficiency (O-antigen) antibodies in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation.
Tag hFc
Products description Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    The immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes the acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    Elizabeth Martinez 2024-02-14 13:13:37
    This antigen exhibits good stability and high quality of the data, which is beneficial for Colloidal Gold Immunochromatographic Assay. They provide a guarantee of regular and permanent efficacy of the processes carried out.

    Leave a comment